GE Healthcare donates Lullaby Warmers to 8 children's hospitals in India
GE Healthcare, the US$ 17 billion healthcare and life sciences solutions business of global major General Electric Company, has donated a Lullaby Warmer each to eight selected children's hospitals across India. The donation is part of GE's 'healthymagination' initiative which aims to improve costs, quality and access to affordable healthcare.
The eight hospitals are the Chennai-based Kanchi Kamakoti Child Trust Hospital, Institute of Child Health, Indira Gandhi Institute of Child Health - Bangalore, KEM Hospital - Pune, SSKM Hospital - Kolkata, Ram Manohar Lohia Hospital - Delhi, Niloufer Hospital - Hyderabad and Sree Avittam Tirunal Mother & Child Hospital at Thiruvananthapuram.
These charitable and government hospitals cater to the needs of a large number of neonates and play a vital role in saving their lives at birth. The new Lullaby Warmer will greatly enhance their neonatal suite and provide care to 70-100 additional newborns.
The Lullaby Warmer, a healthymagination validated product, has the potential to help hospitals improve access to quality infant care in developing countries where nearly 90 per cent of the world's births occur.
"In India, around 1.2 million infants die within a month of birth accounting for almost one fourth of global infant deaths. Many of these deaths are preventable if there is access to quality care solutions. Cost and quality are the twin challenges to creating healthcare access. We are committed to reducing costs, and improving quality and access to affordable healthcare and help save precious lives. The development of Lullaby Warmer in India and this donation is a small example and testimony of our commitment," said V Raja, president & CEO, GE Healthcare South Asia.
GE Healthcare provides medical technologies like imaging, diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies to enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions at early stage.